ArticleScientific reports2015

Assessment of pharmacokinetic compatibility of short acting CDRI candidate trioxane derivative, 99-411, with long acting prescription antimalarials, lumefantrine and piperaquine.

Isha Taneja et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.